R&D Systems Inc. Tocris Bioscience Boston Biochem

Piclamilast

Cat. No. 4525

Piclamilast C18H18Cl2N2O3 [144035-83-6]

Price and Availability

For Piclamilast pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Alternative Name: RP 73401

Chemical Name: 3-(Cyclopentyloxy)-N-(3,5-dichloro-­4-pyridinyl)-4-methoxybenzamide

Biological Activity

Potent and selective inhibitor of phosphodiesterase (PDE) 4 (IC50 = 1 nM at PDE4 from human neutrophils). Displays >19,000-fold selectivity over other PDE isoenzymes. Exhibits anti-inflammatory effects in models of allergic inflammation. Also inhibits LTB4 synthesis in human neutrophils (IC50 = 2 nM).

Technical Data

M.Wt:
381.25
Formula:
C18H18Cl2N2O3
Solubility:
Soluble to 100 mM in DMSO
Purity:
>99 %
Storage:
Store at RT
CAS No:
144035-83-6

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Raeburn et al (1994) Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br.J.Pharmacol. 113 1423. PMID: 7889300.

Hatzelmann and Schudt (2001) Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J.Pharmacol.Exp.Ther. 297 267. PMID: 11259554.

Zhao et al (2003) Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram. J.Pharmacol.Exp.Ther. 305 565. PMID: 12704225.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: Piclamilast, supplier, RP73401, phosphodiesterases, pde4, potent, selective, inhibitors

Quick Order

Find multiple products by catalog number

divider line

New Therapies and Challenges in Asthma

Written by Peter J. Barnes

Asthma Poster

'New Therapies, Challenges, and Breakthroughs in Asthma' highlights key pathways and new therapies used to treat asthma, including those currently in clinical development.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

3-Cyano-7-ethoxycoumarin

Fluorescent cytochrome P450 substrate

Sign-up for new product e-alerts
divider line

Tocris Events

Win a Kindle

11th Congress of the French Neuroscience Society

11th Congress of the French Neuroscience Society

May 21 - 24, 2013

Lyon, France

Booth Number: 32